logo

For the Inventor, By the Inventor

New York, NY, United States of America

Sylvia Lee-Huang

This inventor holds 9 USPTO granted patents and 1 published patent application. Top assignees: New York University, American Biosciences, Inc., The General Hospital Corporation. Active years: 1986-2015.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Sylvia Lee-Huang. Retrieved from https://idiyas.com/inventor/sylvia-lee-huang

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 9 

% Patents Active = 66.7

Average Co-Inventor Count = 2.7

ph-index = 3

Forward Citations = 38(Granted Patents)


Company Filing History:

goldMedal8 out of 1,727 
 
New York University
 patents
silverMedal3 out of 3 
 
American Biosciences, Inc.
 patents
bronzeMedal2 out of 3,071 
 
The General Hospital Corporation
 patents
4. 1 out of 1,217 
 
The United States of America as Represented by the Department of Health
 patents
5. 1 out of 2,202 
 
The United States of America as Represented by the Secretary of
 patents
6. 1 out of 3,693 
 
The United States of America, as Represented by the Secretary, Department of Health and Human Services
 patents
7. 1 out of 834,453 
Other
 patents
where one patent can have more than one assignee

Years Active: 1986-2015

Loading Chart...
9 patents (USPTO):Explore Patents
1. 9132145 - Compositions and methods for treating obesity, obesity related disorders and for inhibiting the infectivity of human immunodeficiency virus (2015-09-15),
2. 8911935 - Mitochondria and human immunodefiency virus type 1 (2014-12-16),
3. 8574635 - Compositions and methods for treating obesity, obesity related disorders and for inhibiting the infectivity of human immunodeficiency virus (2013-11-05),
4. 7838275 - Anti-HIV and anti-tumor peptides and fragments of lysozyme (2010-11-23),
5. 6652861 - Anti-HIV and anti-tumor peptides and truncated polypeptides of MAP30 (2003-11-25),
6. 5532214 - Anti-HIV protein, TAP 29, from tricosanthes, DNA coding therefor and (1996-07-02),
7. 5484889 - Plant protein useful for treating tumors and HIV infection (1996-01-16),
8. 5317009 - Anti-HIV proteins GAP 31, DAP 30 and DAP 32 and therapeutic uses thereof (1994-05-31),
9. 4568488 - Reverse immunoaffinity chromatography purification method (1986-02-04),

Title: Sylvia Lee-Huang: Innovator in Obesity and HIV Research

Introduction

Sylvia Lee-Huang is a prominent inventor based in New York, NY (US), known for her significant contributions to the fields of obesity treatment and HIV research. With a total of 9 patents, her work focuses on developing innovative methods and compositions that address critical health issues.

Latest Patents

Among her latest patents, one notable invention is related to compositions and methods for treating obesity and obesity-related disorders. This invention involves administering oleuropein and its derivatives to individuals suffering from or predisposed to obesity. Additionally, she has developed methods for screening subjects for obesity-related disorders by measuring the expression profiles of specific adipogenic genes. Another significant patent addresses the role of mitochondria in HIV-1 infection, providing methods for modulating cell-to-cell transmission of the virus.

Career Highlights

Sylvia has worked with esteemed organizations such as New York University and American Biosciences, Inc. Her research has led to groundbreaking advancements in understanding and treating obesity and HIV, showcasing her dedication to improving public health.

Collaborations

Throughout her career, Sylvia has collaborated with notable individuals, including Paul L Huang and Philip L Huang. These partnerships have contributed to her innovative research and the development of her patents.

Conclusion

Sylvia Lee-Huang's work exemplifies the impact of innovation in addressing pressing health challenges. Her contributions to obesity treatment and HIV research continue to inspire advancements in medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…